Recombinant Mouse GZMK Protein，His

GZMK, or granulocyte aminopeptidase M, is a member of the peptidase M family and plays a significant role in immune responses and inflammation. Recent studies have emphasized its potential implications in various diseases, particularly in cancer and autoimmune disorders. The protein is primarily expressed in activated T cells and plays a crucial role in regulating immune cell functions and mediating cellular interactions. Its involvement in the processing of peptides for major histocompatibility complex (MHC) class II presentation enhances our understanding of T cell activation and the adaptive immune system. Research into GZMK recombinant proteins has gained momentum due to their potential applications in immunotherapy and vaccine development. By elucidating the structure-function relationship and the underlying mechanisms of GZMK, scientists aim to leverage its unique properties to enhance anti-tumor responses and modulate immune tolerance. Furthermore, the production of recombinant GZMK proteins facilitates the exploration of their biochemical properties, opening avenues for therapeutic interventions. Understanding GZMK's functional dynamics could lead to innovative strategies for treating immune-related diseases and improving vaccine efficacy in the context of infectious diseases and cancer. As such, GZMK has emerged as a promising target in both basic and applied biomedical research, warranting further investigation into its role in health and disease.